Analgesic Infusion Pumps Market Expected to Reach USD 1.72 Billion...

Analgesic Infusion Pumps Market Expected to Reach USD 1.72 Billion By 2032

Posted 2023-11-01 04:50:30

Market Overview: The global analgesic infusion pumps market reached a value of USD 1.17 Billion in 2022 and is projected to attain USD 1.72 Billion by 2032, with a compound annual growth rate (CAGR) of 4.4% during the forecast period. Key drivers for this growth include the increasing prevalence of chronic pain among the elderly, a growing demand for pain management during surgical procedures, and a rising number of surgeries performed worldwide.

Elderly individuals commonly suffer from chronic pain, necessitating long-term analgesic therapy. Consequently, the geriatric population is exhibiting a heightened demand for analgesic infusion pumps, which is anticipated to fuel market growth throughout the forecast period.

Analgesic infusion pumps are increasingly being used in surgical procedures due to their ability to provide targeted pain relief while minimizing side effects. Their application in post-operative pain management is on the rise, as they effectively deliver continuous, focused pain relief.

Get a sample copy of the Analgesic Infusion Pumps Market report: https://www.reportsanddata.com/download-free-sample/6211

The surge in surgical procedures worldwide is contributing to the growing demand for analgesic infusion pumps. The necessity for efficient pain management during surgical procedures is further propelling the market's revenue growth.

The market is also benefiting from the increasing popularity of ambulatory infusion pumps, which are portable and lightweight, making them ideal for patients in need of continuous infusion therapy who wish to maintain their mobility.

Moreover, the rising prevalence of cancer is a significant factor driving revenue growth in the analgesic infusion pumps market, as cancer patients often experience chronic pain that requires ongoing pain management.

Key Insights:

Product Type: The global analgesic infusion pumps market is categorized into Patient-Controlled Analgesia (PCA) Pumps, ambulatory infusion pumps, disposable infusion pumps, and others based on application. In 2022, the PCA pumps segment accounted for the largest share of revenue. PCA pumps are commonly used in hospitals to allow patients to self-administer pain medication, enhancing pain management and reducing healthcare costs. Healthcare professionals prefer PCA pumps due to their simplicity and convenience, which is expected to drive growth in this segment.

The ambulatory infusion pumps segment is anticipated to achieve the highest CAGR in revenue during the forecast period. These pumps are designed to provide patients with medication outside of a hospital setting, enabling them to receive care while maintaining their regular routines. The demand for ambulatory infusion pumps is expected to rise with the increasing prevalence of chronic diseases such as cancer and diabetes, as well as the popularity of home healthcare services and the transition to value-based care.

The disposable infusion pump segment is expected to exhibit a significantly rapid CAGR in revenue during the forecast period. These pumps are cost-effective for healthcare providers since they are single-use and disposable after use. They also reduce the risk of infection transmission, making them a safe choice for patients. These factors are contributing to the revenue growth of this segment.

Application: Based on application, the global analgesic infusion pumps market is divided into Cancer Pain, labor pain, postoperative pain, and others. The cancer pain segment held the largest share of revenue in 2022, as analgesic infusion pumps are used to manage the prevalent symptom of cancer pain. With increasing cancer rates worldwide and the availability of a variety of analgesic medications, both opioids and non-opioids, this segment is expected to see continued growth.

The labor pain segment is projected to experience a significantly rapid CAGR in revenue during the forecast period. Analgesic infusion pumps are employed for managing labor pain, which is a typical symptom of childbirth for women. The rising acceptance of pain management strategies during childbirth, increasing awareness of the benefits of analgesic infusion pumps, and the demand for painless childbirth are driving the growth of this segment.

The postoperative pain segment is also anticipated to register a significantly rapid CAGR in revenue during the forecast period. Postoperative pain is a common occurrence following surgery, and analgesic infusion pumps are effective in managing this discomfort. The segment's growth is attributed to the increasing number of surgeries performed worldwide, the utilization of pain management strategies, and the availability of a variety of analgesic medications.

Regional Insights: In 2022, North America accounted for the largest share of revenue in the market. This is primarily due to factors such as the increasing elderly population and a higher prevalence of chronic diseases. The market in North America benefits from favorable reimbursement policies and a well-established healthcare infrastructure. The United States held the largest share of revenue within North America, driven by the rising prevalence of chronic diseases and an increasing elderly population.

The Asia Pacific market is expected to register the fastest CAGR in revenue during the forecast period. This growth is attributed to the region's focus on expanding healthcare access and improving healthcare facilities, particularly in countries like China and India. Increasing disposable income, a growing demand for innovative medical devices, favorable government initiatives, and healthcare infrastructure investments are expected to drive revenue growth in the region.

The European market is projected to account for a moderately large share of revenue during the forecast period. This is driven by the increasing prevalence of chronic diseases and the adoption of innovative medical technology. The United Kingdom dominates the European market due to its utilization of new medical technology, supportive government policies, and the presence of leading infusion pump manufacturers.

Competitive Landscape: The analgesic infusion pumps market is highly competitive, with several major players vying for market share. Key companies in this market include Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Halyard Health, Hospira Inc. (Pfizer Inc.), Medtronic, Smiths Medical (Smiths Group plc), Terumo Corporation, and Zyno Medical. These companies continuously innovate by developing new products and technologies to enhance patient outcomes and reduce costs. They also engage in strategic alliances and acquisitions to expand their product portfolios and increase their market presence.

Report Scope:

The market size in 2022: USD 1.17 Billion
CAGR (2022 - 2032): 4.4%
Revenue forecast in 2032: USD 1.72 Billion
Base year for estimation: 2022
Historical data: 2020-2021
Forecast period: 2022-2032
Quantitative units: Revenue in USD Billion
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered: Product Type Outlook, Application Outlook, Regional Outlook
By Product Type Outlook: Patient-Controlled Analgesia Pumps, Ambulatory Infusion Pumps, Disposable Infusion Pumps, Others
By Application Outlook: Cancer Pain, Labor Pain, Postoperative Pain, Others
Regional scope: North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country scope: U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey

Explore Trending Reports:

Cellulose Ether Market-https://www.globenewswire.com/news-release/2019/07/18/1884739/0/en/Cellulose-Ether-Market-To-Reach-USD-8-68-Billion-By-2026-Reports-And-Data.html

Synthetic Gypsum Market-https://www.globenewswire.com/news-release/2019/09/16/1916025/0/en/Synthetic-Gypsum-Market-To-Reach-USD-1-89-Billion-By-2026-Reports-And-Data.html

Dimethylformamide (DMF) Market-https://www.globenewswire.com/news-release/2019/11/21/1951122/0/en/Dimethylformamide-DMF-Market-To-Reach-USD-923-9-Million-By-2026-Reports-And-Data.html

Optical Brighteners Market-https://www.globenewswire.com/news-release/2020/05/06/2028786/0/en/Optical-Brighteners-Market-To-Reach-USD-1-44-Billion-By-2027-Reports-and-Data.html

Request a customization of the report: https://www.reportsanddata.com/request-customization-form/6211

Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports